Stonepine Capital Management
CASM

Stonepine Capital Management’s CAS Medical Systems, Inc. CASM Stock Holding History

Stonepine Capital Management’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-812,718
Closed -$748K – 34
2017
Q3 		$748K Sell
812,718
-87,648
-10% -$89.8K 0.44% 19
2017
Q2 		$1.04M Buy
+900,366
New +$1.03M 0.56% 23

Other funds holding CASM

Acuta Capital Partners
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
TD Capital Management
TD Capital Management Memphis, Tennessee $1.23B AUM 7.62% 1-Year Est. Return
Penbrook Management
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Curi RMB Capital
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return

Stonepine Capital Management's CASM Position: Q4 2017 in Review

Stonepine Capital Management sold out of CAS Medical Systems, Inc. (CASM) in Q4 2017, closing a stake of 812,718 shares — an estimated $748K sold.

Stonepine Capital Management first reported a position in CASM in Q2 2017 and held it in 2 quarters. The position peaked at $1.04M in Q2 2017. 19 funds tracked by Wall St. Rank hold CASM as of Q4 2017.

  • Stonepine Capital Management reported no remaining CAS Medical Systems, Inc. position as of Q4 2017 after selling out during the quarter.
  • Stonepine Capital Management sold 812,718 CAS Medical Systems, Inc. shares in Q4 2017, an estimated $748K.
  • Stonepine Capital Management first reported a position in CAS Medical Systems, Inc. in Q2 2017 and held it in 2 quarters.
  • Stonepine Capital Management's CAS Medical Systems, Inc. position peaked at $1.04M in Q2 2017.
  • 19 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q4 2017.

Based on Stonepine Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.